Shared Facility Audit Findings and CAPA Examples

Identifying symptoms of contamination or non-compliance in a shared facility is crucial to maintaining drug quality and safety standards. These symptoms may manifest through various channels:Click to read the full…

How to Use Risk-Based Sampling in Shared Facilities

Implementing Risk-Based Sampling Strategies for Shared Facilities in Pharma Manufacturing In multi-product pharmaceutical manufacturing environments, managing risks associated with contamination is paramount. The challenge of implementing effective cross-contamination controls in…

How to Define Acceptable Carryover in Shared Facilities

Guidelines for Effective Management of Acceptable Carryover in Multi-Product Facilities In the context of shared facilities, managing acceptable carryover (ACO) is critical to ensure product quality and patient safety. This…

How to Manage Contractor Work in Shared GMP Areas

Identifying early symptoms or signals of non-compliance or contamination risks is crucial for effective shared facility risk management. Common indicators include:Click to read the full article.

Shared Facility Risk Management During Tech Transfer

Identifying and addressing symptoms of potential contamination or procedural failure in shared facilities is paramount to maintaining product integrity. Key indicators of risk may include:Click to read the full article.

Shared Facility Controls for Visual Residue Inspection

Recognizing early warning signals is crucial in any quality management system, particularly in shared facilities. Symptoms associated with inadequate visual residue inspections may include:Click to read the full article.